Top compounds associated with response to SRP19


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.074 0.03
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.088 0.04
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.076 0.04
mRNA decitabine CTRPv2 pan-cancer AAC -0.058 0.04
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.04
mRNA tivozanib CTRPv2 pan-cancer AAC -0.076 0.04
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.091 0.04
mRNA lapatinib UHNBreast pan-cancer AAC -0.58 0.04
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.04
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.073 0.04
Download CSV